Cargando…
Aberrant RNA Splicing in Cancer and Drug Resistance
More than 95% of the 20,000 to 25,000 transcribed human genes undergo alternative RNA splicing, which increases the diversity of the proteome. Isoforms derived from the same gene can have distinct and, in some cases, opposing functions. Accumulating evidence suggests that aberrant RNA splicing is a...
Autores principales: | Wang, Bi-Dar, Lee, Norman H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266310/ https://www.ncbi.nlm.nih.gov/pubmed/30463359 http://dx.doi.org/10.3390/cancers10110458 |
Ejemplares similares
-
Aberrant splicing and drug resistance in AML
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2016) -
Molecular Insight into Drug Resistance Mechanism Conferred by Aberrant PIK3CD Splice Variant in African American Prostate Cancer
por: Ha, Siyoung, et al.
Publicado: (2023) -
Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
por: Kitamura, Koji, et al.
Publicado: (2021) -
Aberrant RNA splicing and therapeutic opportunities in cancers
por: Yamauchi, Hirofumi, et al.
Publicado: (2021) -
Aberrant alternative splicing in breast cancer
por: Yang, Quan, et al.
Publicado: (2019)